{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:54:21Z","timestamp":1790603661457,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad Central del Ecuador"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Antibiotic resistance is a global threat to public health, and the search for new antibacterial therapies is a current research priority. The aim of this in silico study was to test nine new fluoroquinolones previously designed with potential leishmanicidal activity against Campylobacter jejuni, Escherichia coli, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Salmonella typhi, all of which are considered by the World Health Organization to resistant pathogens of global concern, through molecular docking and molecular dynamics (MD) simulations using wild-type (WT) and mutant-type (MT) DNA gyrases as biological targets. Our results showed that compound 9FQ had the best binding energy with the active site of E. coli in both molecular docking and molecular dynamics simulations. Compound 9FQ interacted with residues of quinolone resistance-determining region (QRDR) in GyrA and GyrB chains, which are important to enzyme activity and through which it could block DNA replication. In addition to compound 9FQ, compound 1FQ also showed a good affinity for DNA gyrase. Thus, these newly designed molecules could have antibacterial activity against Gram-negative microorganisms. These findings represent a promising starting point for further investigation through in vitro assays, which can validate the hypothesis and potentially facilitate the development of novel antibiotic drugs.<\/jats:p>","DOI":"10.3390\/molecules28196929","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T11:58:57Z","timestamp":1696420737000},"page":"6929","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel Fluoroquinolones with Possible Antibacterial Activity in Gram-Negative Resistant Pathogens: In Silico Drug Discovery"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5850-3733","authenticated-orcid":false,"given":"Manuel Alejandro","family":"Coba-Males","sequence":"first","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Biodiversidad, Zoonosis y Salud P\u00fablica (GIBCIZ), Instituto de Salud P\u00fablica y Zoonosis (CIZ), Facultad de Ciencias Qu\u00edmicas (FCQ), Universidad Central del Ecuador, Quito 170521, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-4237","authenticated-orcid":false,"given":"Martin J.","family":"Lavecchia","sequence":"additional","affiliation":[{"name":"CEQUINOR (UNLP-CONICET, CCT-La Plata, Associated with CICBA), Universidad Nacional de La Plata, La Plata 1900, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-3107","authenticated-orcid":false,"given":"Christian David","family":"Alc\u00edvar-Le\u00f3n","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Qu\u00edmicas (FCQ), Universidad Central del Ecuador, Quito 170521, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-5737","authenticated-orcid":false,"given":"Javier","family":"Santamar\u00eda-Aguirre","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Biodiversidad, Zoonosis y Salud P\u00fablica (GIBCIZ), Instituto de Salud P\u00fablica y Zoonosis (CIZ), Facultad de Ciencias Qu\u00edmicas (FCQ), Universidad Central del Ecuador, Quito 170521, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"ref_1","unstructured":"OMS (2023, February 20). Resistencia a Los Antibi\u00f3ticos. Available online: http:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/resistencia-a-los-antibi\u00f3ticos."},{"key":"ref_2","unstructured":"O\u2019Neill, J. (2023, March 03). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Available online: https:\/\/apo.org.au\/node\/63983."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"339","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_4","first-page":"4","article-title":"Resistencia Bacteriana: Un Problema de Salud P\u00fablica Mundial de Dif\u00edcil Soluci\u00f3n","volume":"14","year":"2016","journal-title":"Mem. Inst. Investig. Cienc. Salud"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Serweci\u0144ska, L. (2020). Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health. Water, 12.","DOI":"10.3390\/w12123313"},{"key":"ref_6","unstructured":"OMS (2023, February 25). La OMS Publica La Lista de Las Bacterias Para Las Que Se Necesitan Urgentemente Nuevos Antibi\u00f3ticos. Available online: https:\/\/www.who.int\/es\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103424","DOI":"10.1016\/j.sjbs.2022.103424","article-title":"In-Silico Investigation of a Novel Inhibitors against the Antibiotic-Resistant Neisseria Gonorrhoeae Bacteria","volume":"29","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Alhadrami, H.A., Abdulaal, W.H., Hassan, H.M., Alhakamy, N.A., and Sayed, A.M. (2022). In Silico-Based Discovery of Natural Anthraquinones with Potential against Multidrug-Resistant E. Coli. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010086"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11224-022-01887-2","article-title":"Assessment of Activity of Chalcone Compounds as Inhibitors of 3-Chymotrypsin like Protease (3CLPro) of SARS-CoV-2: In Silico Study","volume":"33","author":"Mathpal","year":"2022","journal-title":"Struct. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2023). Design and Synthesis of Novel Antimicrobial Agents. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030628"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.2174\/0929867325666180214122944","article-title":"Current Trends and Future Directions of Fluoroquinolones","volume":"26","author":"Mohammed","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_12","first-page":"26","article-title":"Fluoroquinolone Antibiotics: An Overview","volume":"2","author":"Brar","year":"2020","journal-title":"Adesh Univ. J. Med. Sci. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone Antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"Med. Chem. Commun."},{"key":"ref_14","first-page":"e83","article-title":"Quinolonas En Pediatr\u00eda","volume":"19","author":"Alfayate","year":"2017","journal-title":"Rev. Pediatr\u00eda Atenci\u00f3n Primaria"},{"key":"ref_15","first-page":"1","article-title":"Quinolonas","volume":"16","author":"Serra","year":"2008","journal-title":"Separata"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/15257770008033048","article-title":"The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action","volume":"19","author":"Heddle","year":"2000","journal-title":"Nucleosides, Nucleotides and Nucleic Acids"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","article-title":"DNA Gyrase Inhibitors: Progress and Synthesis of Potent Compounds as Antibacterial Agents","volume":"103","author":"Khan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/00365540410019039","article-title":"The Fluoroquinolones: How Long Will Their Utility Last?","volume":"36","author":"Bakken","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4067\/S0716-10182015000600002","article-title":"Quinolonas. Perspectivas Actuales y Mecanismos de Resistencia","volume":"32","author":"Garza","year":"2015","journal-title":"Rev. Chil. Infectol."},{"key":"ref_20","unstructured":"Jacho, M. (2020). M\u00e9todos Computacionales Para El Dise\u00f1o de Fluoroquinolonas Con Alta Afinidad Por Topoisomerasa II de Leishmania. [Bachelor\u2019s Thesis, Universidad Central del Ecuador]."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e24655","DOI":"10.1002\/jcla.24655","article-title":"Antibiotic Resistance: The Challenges and Some Emerging Strategies for Tackling a Global Menace","volume":"36","author":"Ugwu","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_22","unstructured":"WHO (2023, April 02). WHO Antibiotic Categorization. Available online: https:\/\/aware.essentialmeds.org\/groups."},{"key":"ref_23","unstructured":"ONU (2023, March 05). La Incapacidad Para Fabricar Antibi\u00f3ticos Nuevos Favorece La Resistencia de Las Bacterias a Los Medicamentos. Available online: https:\/\/news.un.org\/es\/story\/2021\/04\/1490872."},{"key":"ref_24","first-page":"55","article-title":"Acomplamiento Molecular: Criterios Pr\u00e1cticos Para La Selecci\u00f3n de Ligandos Biol\u00f3gicamente Activos e Identificaci\u00f3n de Nuevos Blancos Terap\u00e9uticos","volume":"7","author":"Grados","year":"2019","journal-title":"Rev. Con-Ciencia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","article-title":"In Silico Methods and Tools for Drug Discovery","volume":"137","author":"Shaker","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/cbic.200800041","article-title":"Mechanism of Binding of Fluoroquinolones to the Quinolone Resistance-Determining Region of DNA Gyrase: Towards an Understanding of the Molecular Basis of Quinolone Resistance","volume":"9","author":"Madurga","year":"2008","journal-title":"ChemBioChem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamem.2012.05.027","article-title":"Mechanism for Translocation of Fluoroquinolones across Lipid Membranes","volume":"1818","author":"Cramariuc","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12879-023-08086-2","article-title":"Fluoroquinolone Resistance among Fecal Extended Spectrum \u0392eta Lactamases Positive Enterobacterales Isolates from Children in Dar Es Salaam, Tanzania","volume":"23","author":"Kibwana","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fphar.2019.01145","article-title":"Estimating Factors Related to Fluoroquinolone Resistance Based on One Health Perspective: Static and Dynamic Panel Data Analyses from Europe","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_30","first-page":"93","article-title":"Burden of Fluoroquinolone Resistance in Clinical Isolates of Escherichia Coli at the Ho Teaching Hospital, Ghana","volume":"32","author":"Deku","year":"2022","journal-title":"Ethiop. J. Health Sci."},{"key":"ref_31","first-page":"504","article-title":"Prevalence of Fluoroquinolone Resistance in Escherichia Coli in an Indian Teaching Hospital and Adjoining Communities","volume":"10","author":"Rath","year":"2015","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jmii.2022.08.017","article-title":"Correlation between Antibiotic Consumption and Resistance of Pseudomonas Aeruginosa in a Teaching Hospital Implementing an Antimicrobial Stewardship Program: A Longitudinal Observational Study","volume":"56","author":"Huang","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Donkor, E.S., Muhsen, K., Johnson, S.A.M., Kotey, F.C.N., Dayie, N.T.K.D., Tetteh-Quarcoo, P.B., Tette, E.M.A., Osei, M.M., Egyir, B., and Nii-Trebi, N.I. (2023). Multicenter Surveillance of Antimicrobial Resistance among Gram-Negative Bacteria Isolated from Bloodstream Infections in Ghana. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020255"},{"key":"ref_34","first-page":"129","article-title":"Penetraci\u00f3n de Los Antibi\u00f3ticos de Los Polimorfonucleares Humanos, Con Especial Referencia a Las Quinolonas","volume":"15","author":"Orero","year":"2002","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5599\/admet.657","article-title":"Permeation Characteristics of Tetracyclines in Parallel Artificial Membrane Permeation Assay","volume":"7","author":"Yamauchi","year":"2019","journal-title":"ADMET DMPK"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejps.2017.03.040","article-title":"Kinetics of Lipid Bilayer Permeation of a Series of Ionisable Drugs and Their Correlation with Human Transporter-Independent Intestinal Permeability","volume":"104","author":"Hermann","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/jm901421c","article-title":"The Permeation of Amphoteric Drugs through Artificial Membranes--an in Combo Absorption Model Based on Paracellular and Transmembrane Permeability","volume":"53","author":"Tam","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40199-020-00373-6","article-title":"Design, Synthesis, Molecular Docking Study, and Antibacterial Evaluation of Some New Fluoroquinolone Analogues Bearing a Quinazolinone Moiety","volume":"28","author":"Norouzbahari","year":"2020","journal-title":"DARU, J. Pharm. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.56499\/jppres18.368_6.5.386","article-title":"Docking Studies on Novel Analogs of Quinolones against DNA Gyrase of Escherichia Coli","volume":"6","author":"Davila","year":"2018","journal-title":"J. Pharm. Pharmacogn. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hou, Y., Zhao, Y., and Li, Y. (2020). Environmentally Friendly Fluoroquinolone Derivatives with Lower Plasma Protein Binding Rate Designed Using 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17186626"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Pantsar, T., and Poso, A. (2018). Binding Affinity via Docking: Fact and Fiction. Molecules, 23.","DOI":"10.3390\/molecules23081899"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1039\/C8MD00148K","article-title":"Identification of an Auxiliary Druggable Pocket in the DNA Gyrase ATPase Domain Using Fragment Probes","volume":"9","author":"Huang","year":"2018","journal-title":"Med. Chem. Commun."},{"key":"ref_44","first-page":"1794","article-title":"In-Silico Identification and Molecular Docking Studies of Quinolone Resistance Determining Region (QRDR) of E.Coli DNA Gyrase-a with Ofloxacin Schiff Bases","volume":"5","author":"Susanta","year":"2013","journal-title":"Int. J. PharmTech Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: An Advanced Semantic Chemical Editor, Visualization, and Analysis Platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminform."},{"key":"ref_46","unstructured":"ChemAxon (2022, September 02). MarvinSketch (Version 21.12.0). Available online: https:\/\/chemaxon.com\/marvin."},{"key":"ref_47","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., and Petersson, G.A. (2009). Gaussian09. Revision D01, Gaussian, Inc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA Topoisomerase Inhibition by a New Class of Antibacterial Agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the Worldwide Protein Data Bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: The Universal Protein Knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1590\/0103-8478cr20141712","article-title":"Detection of Fluoroquinolone Resistance by Mutation in GyrA Gene of Campylobacter Spp. Isolates from Broiler and Laying (Gallus Gallus Domesticus) Hens, from Rio de Janeiro State, Brazil","volume":"45","author":"Medeiros","year":"2015","journal-title":"Ci\u00eancia Rural"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e0190729","DOI":"10.1371\/journal.pone.0190729","article-title":"Analytical Profiling of Mutations in Quinolone Resistance Determining Region of GyrA Gene among UPEC","volume":"13","author":"Varughese","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12866-019-1439-1","article-title":"GyrA and ParC Mutations in Fluoroquinolone-Resistant Neisseria Gonorrhoeae Isolates from Kenya","volume":"19","author":"Kivata","year":"2019","journal-title":"BMC Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13756-020-00793-8","article-title":"Development of in Vitro Resistance to Fluoroquinolones in Pseudomonas Aeruginosa","volume":"9","author":"Zhao","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_55","first-page":"337","article-title":"Persistent Circulation of a Fluoroquinolone-Resistant Salmonella Enterica Typhi Clone in the Indian Subcontinent","volume":"75","author":"Britto","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera - A Visualization System for Exploratory Research and Analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","article-title":"FRED and HYBRID Docking Performance on Standardized Datasets","volume":"26","author":"McGann","year":"2012","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_59","unstructured":"The PyMOL Molecular Graphics System v.1.3. (2022, September 20). Schr\u00f6dinger, LLC. Available online: https:\/\/www.pymol.org\/pymol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable Molecular Dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/acs.jctc.6b00186","article-title":"Assessing the Current State of Amber Force Field Modifications for DNA","volume":"12","author":"Robertson","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and Testing of a General Amber Force Field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_64","unstructured":"Case, D.A., Aktulga, H.M., Belfon, K., Ben-Shalom, I.Y., Berryman, J.T., Brozell, S.R., Cerutti, D.S., T.E. Cheatham, I., Cisneros, G.A., and Cruzeiro, V.W.D. (2022). Amber 2022; University of California."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: An Efficient Program for End-State Free Energy Calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: A Webserver for the Prediction of Toxicity of Chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/19\/6929\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:14Z","timestamp":1760130314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/19\/6929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":67,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["molecules28196929"],"URL":"https:\/\/doi.org\/10.3390\/molecules28196929","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]}}}